Detalles de la búsqueda
1.
Safety and efficacy of bosutinib in fourth-line therapy of chronic myeloid leukemia patients.
Ann Hematol
; 98(2): 321-330, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30446802
2.
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program.
Am J Hematol
; 90(5): 429-33, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25683327
3.
COVID-19 Severity and Survival over Time in Patients with Hematologic Malignancies: A Population-Based Registry Study.
Cancers (Basel)
; 15(5)2023 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36900296
4.
Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: results of a Spanish multicenter study.
Transfus Apher Sci
; 43(3): 299-303, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20934383
5.
Haematopoietic transplants combining a single unrelated cord blood unit and mobilized haematopoietic stem cells from an adult HLA-mismatched third party donor. Comparable results to transplants from HLA-identical related donors in adults with acute leukaemia and myelodysplastic syndromes.
Best Pract Res Clin Haematol
; 23(2): 259-74, 2010 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-20837338
Resultados
1 -
5
de 5
1
Próxima >
>>